Status:
TERMINATED
F-18 PSMA for Localization of Parathyroid Adenoma
Lead Sponsor:
Emory University
Conditions:
Hyperparathyroidism
Eligibility:
All Genders
18-99 years
Brief Summary
Parathyroid glands are in the neck and produce a substance called parathormone which maintains the calcium level in the blood. Sometimes one or more of the parathyroid glands become hyperactive and pr...
Detailed Description
Hyperparathyroidism is an increasingly significant medical and public health condition in the United States. In the past two decades, the incidence of hyperparathyroidism has increased 300%, and curre...
Eligibility Criteria
Inclusion
- Patients must be 18 years of age or older.
- Patients will have biochemical and/or clinical evidence of primary hyperparathyroidism and be a surgical candidate for definitive parathyroid surgery.
- Ability to lie still for SPECT/CT and PET/CT scanning
- Patients must be able to provide written informed consent
Exclusion
- Age less than 18.
- Inability to lie still for SPECT/CT and PET/CT scanning.
- Cannot provide written informed consent.
- History of secondary hyperparathyroidism.
- Positive serum or urine pregnancy test within 24 hours of imaging
Key Trial Info
Start Date :
March 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 9 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05299632
Start Date
March 31 2022
End Date
May 9 2022
Last Update
May 9 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States, 30308
2
Emory University Hospital (EUH)
Atlanta, Georgia, United States, 30322
3
Emory Johns Creek Hospital
Johns Creek, Georgia, United States, 30097